» Articles » PMID: 35465051

MiRNA/mRNA Co-profiling Identifies the MiR-200 Family As a Central Regulator of SMC Quiescence

Overview
Journal iScience
Publisher Cell Press
Date 2022 Apr 25
PMID 35465051
Authors
Affiliations
Soon will be listed here.
Abstract

miRNAs are versatile regulators of smooth muscle cell (SMC) fate and behavior in vascular development and disease. Targeted loss-of-function studies have established the relevance of specific miRNAs in controlling SMC differentiation or mediating phenotypic modulation. Our goal was to characterize SMC miRNAome and its contribution to transcriptome changes during phenotypic modulation. Small RNA sequencing revealed that dedifferentiation led to the differential expression of over 50 miRNAs in cultured SMC. miRNA/mRNA comparison predicted that over a third of SMC transcript expression was regulated by differentially expressed miRNAs. Our screen identified the miR-200 cluster as highly downregulated during dedifferentiation. miR-200 maintains SMC quiescence and represses proliferation, migration, and neointima formation, in part by targeting Quaking, a central SMC phenotypic switching mediator. Our study unraveled the substantial contribution of miRNAs in regulating the SMC transcriptome and identified the miR-200 cluster as a pro-quiescence mechanism and a potential inhibitor of vascular restenosis.

Citing Articles

Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series).

Forbes L, Bauer N, Bhadra A, Bogaard H, Choudhary G, Goss K Pulm Circ. 2025; 15(1):e70027.

PMID: 39749110 PMC: 11693987. DOI: 10.1002/pul2.70027.


Peripheral Blood miRNA Expression in Patients with Essential Hypertension in the Han Chinese Population in Hefei, China.

Cheng B, Yang R, Xu H, Wang L, Jiang N, Song T Biochem Genet. 2024; .

PMID: 38907084 DOI: 10.1007/s10528-024-10867-6.


Integrative analysis of the lncRNA-miRNA-mRNA interactions in smooth muscle cell phenotypic transitions.

Mahajan A, Hong J, Krukovets I, Shin J, Tkachenko S, Espinosa-Diez C Front Genet. 2024; 15:1356558.

PMID: 38660676 PMC: 11039880. DOI: 10.3389/fgene.2024.1356558.


Role of mechanoregulation in mast cell-mediated immune inflammation of the smooth muscle in the pathophysiology of esophageal motility disorders.

Goyal R, Rattan S Am J Physiol Gastrointest Liver Physiol. 2024; 326(4):G398-G410.

PMID: 38290993 PMC: 11213482. DOI: 10.1152/ajpgi.00258.2023.


Nuclear Control of Vascular Smooth Muscle Cell Plasticity during Vascular Remodeling.

Ahmed I, Liu M, Gomez D Am J Pathol. 2023; 194(4):525-538.

PMID: 37820925 PMC: 10988766. DOI: 10.1016/j.ajpath.2023.09.013.


References
1.
Wang D, Atanasov A . The microRNAs Regulating Vascular Smooth Muscle Cell Proliferation: A Minireview. Int J Mol Sci. 2019; 20(2). PMC: 6359109. DOI: 10.3390/ijms20020324. View

2.
Liu M, Espinosa-Diez C, Mahan S, Du M, Nguyen A, Hahn S . H3K4 di-methylation governs smooth muscle lineage identity and promotes vascular homeostasis by restraining plasticity. Dev Cell. 2021; 56(19):2765-2782.e10. PMC: 8567421. DOI: 10.1016/j.devcel.2021.09.001. View

3.
Park S, Gaur A, Lengyel E, Peter M . The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008; 22(7):894-907. PMC: 2279201. DOI: 10.1101/gad.1640608. View

4.
Clark P, Loher P, Quann K, Brody J, Londin E, Rigoutsos I . Argonaute CLIP-Seq reveals miRNA targetome diversity across tissue types. Sci Rep. 2014; 4:5947. PMC: 4894423. DOI: 10.1038/srep05947. View

5.
Humphries B, Yang C . The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy. Oncotarget. 2015; 6(9):6472-98. PMC: 4466628. DOI: 10.18632/oncotarget.3052. View